AKT1 and pulmonary fibrosis: This suggests that the inhibitory effect of CDN on EMT is the core phenotypic effect underlying its alleviation of BLM-induced pulmonary fibrosis, and the molecular mechanism of this effect requires further validation through the IGF1/PI3K-AKT pathway.